1 / 7

25 june 2018 daily equity reports

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX.

PeehuSharma
Download Presentation

25 june 2018 daily equity reports

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 25THJUNE 2018 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK:- Benchmark indices closed sharply higher led by recovery in the last hour of trade, backed by banking & financial stocks. The Sensex gained 257.21 points at 35,689.60 and the Nifty rose 80.80 points to 10,821.90 Hexaware, Adani Transmission, United Spirits, Ujjivan Financial, IDBI Bank, Fortis Healthcare, Can Fin Homes, Jet Airways, InterGlobe Aviation, Infibeam, Jubilant Foodworks, Bombay Dyeing, Manappuram Finance and Havells gained up to 8 percent. ASIAN MARKET CLOSE PREVIOUS NIKKEI SECTORIAL INDICES ! Saudi Oil Minister Khalid Al-Falih said he proposed to increase oil supply by 1 mbpd. "1 mbpd supply will be distributed among nations based on their ability to produce.. Roughly 2/3rd supply increases will come from OPEC countries, he said, adding OPEC will meet again in September & make adjustments as needed. GLOBAL FACE CLOSE CHANGE (%) +0.72 9296.65 +0.61 4962.10 +0.38 5786.55 +0.69 +1.02 ! Asian Market - Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.49% and the Hang Seng rose 0.15%. The Nikkei 225 lost 0.78%. CLOSE CHANGE (%) +4.43 ! +3.75 U.S. Market - U.S. stocks close lower on Thursday, with major indexes suffering one of their worst . Charting a market divergence, Dow industrials violate 50-day average +3.13 M&M 910.00 +2.99 ! European markets - European markets are higher today with shares in France leading the region. The CAC 40 is up 0.88% while London's FTSE 100 is up 0.84% and Germany's DAX is up 0.47%. TOP LOSERS CLOSE CHANGE (%) -2.09 -1.97 UPL -1.08 -0.97 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE CHANGE (%) 21.11 STRATEGY SCRIPT CLOSE 52.5 3170 7.92 S3 10535 10662 S2 S1 10741 P R1 10868 R2 10916 RESISTANCE R1-10840 R2-10930 R3 11043 10789 2602.35 7.29 SUPPORT S1-10710 S2-10590 NIFTY 301.50 5.92 MARKET MOVERS DOWNSIDE CHANGE (%) CLOSE PNB HINDALCO 640 FII & DII ACTIVITY NET (CR.) 6385.35 BANK NIFTY FUTURE DII BULLISH BUY ON DIP NSE TOTALS PIVOT POINTS P 26661 S3 S1 26493 R1 R2 R3 ADVANCE 25721 26191 26963 27601 RESISTANCE BANK NIFTY BANK NIFTY 8 4 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! ! Rupee strengthens against US dollar The Indian rupee strengthened against the US dollar for the third straight session on Friday. The rupee was trading at 67.81 against US dollar, up 0.27% from its previous close of 67.99. The home currency opened at 67.85 a dollar and touched a high and a low of 67.71 and 67.88 respectively. Oil prices rise ahead of Opec meeting Oil prices rose by more than 1% on Friday, lifted by uncertainty over whether the Organization of the Petroleum Exporting Countries (Opec) would manage to agree a production increase at a meeting in Vienna later in the day. RITES IPO subscribed 450% so far on last day of issue The initial public offering (IPO) of PSU firm RITES (Rail India Technical and Economic Services Ltd), which was fully subscribed on Thursday, continued to see strong demand. The RITES IPO closes on Friday. As of 12.15 pm, the RITES IPO was subscribed nearly 4.5 times, or 450%, according to NSE data. Astrazeneca Pharma shares jump 5% on drug approval IDBI Bank shares rise 2% after report of stake to LIC Shares of IDBI Bank Ltd gained 2% to Rs59.15 after The Economic Times reported that the government is planning to sell 40% stake in the bank to Life Insurance Corp. of India Ltd. ! ! RIL shares down 2% on block deal Shares of Reliance Industries Ltd fell 2% to Rs 1012 after huge block deal. Around 1.35 million shares of the company changed hands in a block deal, Bloomberg reported. However, details of the buyers and sellers were not known. ! ! UPL share hit 1-1/2 year low Shares of agrochemical maker UPL Ltd declined as much as 2.14% to Rs632.2, their lowest since 29 December 2016. The stock fell below a support at Rs640.2, the 86.4% Fibonacci projection level of the downtrend from 1 August 2017 high to 6 December 2017, suggesting a move towards the next support at Rs610.6, the 100% projection level. Trend Intensity indicator rose to 17, suggesting stock is in early stages of a new downtrend. The stock’s RSI line has faced resistance near 50 level for the last two months, seen bearish for the stock. ! Astrazeneca Pharma India Ltd shares advanced 5% to Rs1,420 after the company said it received marketing permission for Durvalumab (ImfinziTM) in India. The drug is used in treatment for patients with locally advanced, unresectable non-small cell lung cancer and metastatic urothelial carcinoma. . Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Visit us: www.capitalstars.com Call us: 9977499927 O731-6690000 Our services: MCX TIPS INTRADAY STOCK TIPS FINANCIAL ADVISORY COMPANY Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

More Related